ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,010Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 103

$757K Total Retail Price of All Prescriptions

Rank: 9 out of 103

885 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 885 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 885 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 15,234 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
SIMVASTATIN 811 761 1 2
FUROSEMIDE 724 665 2 4
LEVOTHYROXINE SODIUM 657 583 3 1
OMEPRAZOLE 528 435 4 3
LISINOPRIL 510 481 5 5
METOPROLOL SUCCINATE 495 477 6 8
AMLODIPINE BESYLATE 472 455 7 6
WARFARIN SODIUM 402 383 8 7
POTASSIUM CHLORIDE 373 355 9 10
METOPROLOL TARTRATE 337 325 10 9
CITALOPRAM HBR 321 273 11 15
HYDROCODONE-ACETAMINOPHEN 300 241 S3 12 11
TRIAMTERENE-HYDROCHLOROTHIAZID 288 261 10 13 121
METFORMIN HCL 269 231 14 13
DIGOXIN 263 251 15 25
ATENOLOL 250 234 16 14
ALLOPURINOL 232 230 17 26
TAMSULOSIN HCL 215 201 18 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 214 198 19 48
ALENDRONATE SODIUM 203 172 20 19
MIRTAZAPINE 199 181 21 36
GLYBURIDE 191 157 R 22 76
TRAMADOL HCL 171 142 23 17
ATORVASTATIN CALCIUM 171 160 23 18
GABAPENTIN 163 139 25 22
ZOLPIDEM TARTRATE 156 142 26 29
PRAVASTATIN SODIUM 148 133 27 33
HYDROCHLOROTHIAZIDE 146 137 28 16
MELOXICAM 142 133 29 49
ISOSORBIDE MONONITRATE ER 136 136 30 37
CRESTOR 130 122 31 27
FLUTICASONE PROPIONATE 127 103 32 35
AMITRIPTYLINE HCL 123 122 R 33 54
LOSARTAN POTASSIUM 117 117 34 12
POLYETHYLENE GLYCOL 3350 110 110 35 31
NEXIUM 110 86 35 43
VERAPAMIL ER 109 106 37 91
CLOPIDOGREL 109 106 37 32
PREDNISONE 108 105 39 24
SPIRONOLACTONE 105 78 40 30
ACTOS 101 76 41 102
SERTRALINE HCL 97 85 42 21
LOSARTAN-HYDROCHLOROTHIAZIDE 96 78 43 47
ACETAMINOPHEN-CODEINE 93 88 S3 44 122
KLOR-CON 10 88 87 45 45
VENLAFAXINE HCL ER 86 86 46 110
DICLOFENAC SODIUM 83 75 47 142
CEPHALEXIN 82 77 48 72
PLAVIX 76 76 49 46
ESTRADIOL 73 72 R 50 169
LANTUS 73 61 50 39
CIPROFLOXACIN HCL 70 64 52 59
GLIPIZIDE 70 66 52 65
PROPRANOLOL HCL 69 69 54 87
FINASTERIDE 68 64 55 69
TAMIFLU 65 64 56 202
GLYBURIDE-METFORMIN HCL 65 62 R 56 154
TRIAMTERENE-HCTZ 64 64 58 38
CARVEDILOL 64 53 58 20
GEMFIBROZIL 64 52 58 62
TRICOR 63 40 61 206
LOVASTATIN 62 50 62 67
VYTORIN 59 25 63 155
RANITIDINE HCL 59 56 63 53
BENAZEPRIL HCL 55 52 65 93
OXYBUTYNIN CHLORIDE 55 43 65 144
CARBIDOPA-LEVODOPA 54 54 67 55
AMLODIPINE BESYLATE-BENAZEPRIL 53 47 68 118
ZETIA 51 51 69 66
CYMBALTA 51 51 69 60
FLUOXETINE HCL 51 45 69 92
PREMARIN 50 50 R 72 149
NIFEDIPINE ER 50 48 72 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.